ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2024
[Neoadjuvant nivolumab plus chemotherapy followed by response-adaptive therapy for HPV-positive oropharyngeal cancer].
Alexander Rühle et al.PubMed ↗Publisher ↗
No numbers read from the abstract.